Sera from patients with RA and SLE contain circulating immune complexes detectable by a number of assays.1 Circulating immune complexes detected by cryoglobulinaemia in patients with RA are associated with certain extra-articular disease features considered to have a vascular or granulomatous basis.2 3 In patients with SLE cryoglobulinaemia correlates with the presence of renal disease.4 5 The pathogenicity of immune complexes is determined by their ability to localise in target tissues and activate complement, which is in turn related to the size and shape of the immune complexes and their antigen and antibody composition. 6 7 This paper compares the immunoglobulin, rheumatoid factor, DNA antibody, and C3 and C4 composition of cryoglobulins prepared from sera of patients with RA and SLE. It also reports on the ability of these cryoglobulins to bind Clq. Sera from patients with cryoglobulinaemic purpura, conAccepted for publication 13 December 1983. Correspondence to Dr C. C. Erhardt The concentrations of cryoprecipitable immunoglobulin are given in Table 1 , which shows that the predominant immunoglobulin class which precipi- The DNA binding activity of 11 SLE sera, all from patients known to have cryoglobulinaemia, was measured after cold incubation and harvesting of the cryoglobulin and the result compared with the DNA binding activity of a rapidly frozen aliquot of the same serum. Five of the sera showed a fall in DNA binding activity greater than 10 units/ml (110, 50, 25, 20, 18 units/ml) suggesting the incorporation of DNA antibodies into the cryoglobulin.
Serum cryoglobulins from six RA patients, 10 SLE patients, and three patients with cryoglobulinaemic purpura were investigated for the presence of antibodies to extractable nuclear antigens (ENA). No cryoglobulin gave an immunoprecipitin line against rabbit thymus extract by either the counterimmunoelectrophoresis or double diffusion methods. The possibility exists that the absence of reaction might be caused by binding of antibodies to antigen already present in the cryoglobulin. Therefore a further aliquot of each cryoglobulin was treated with RNAse before testing and again no immunoprecipitin lines formed.
COMPLEMENT BINDING BY CRYOGLOBULINS AND THE ANTIGLOBULIN-CONTAINING SERUM
FRACTION
In contrast to the high frequency of Clq-BA of RA sera only two isolated RA serum cryoglobulins out of 34 tested bound Clq (47% and 15%) (Fig. 1) The extent to which immune complexes containing rheumatoid factor accounted for the ClqBA of sera from four RA patients was investigated by an affinity column of aggregated human gammaglobulin bound to sepharose 4B. The results of these experiments, of which those in Table 2 are representative, showed that C1qBA was found mainly in the rheumatoid-factor-rich fraction. Affinity chromatography of a serum with a lower rheumatoid factor titre (1:160, ClqBA:24%) resulted in complete absorption of rheumatoid factor and ClqBA from the first drop-through fraction. The ratio of ClqBA to the sum of IgG and IgM was particularly high in the antiglobulin fraction, suggesting that much of the immunoglobulin in this fraction formed Clq binding immune complexes.
Seven out of 12 isolated cryoglobulins from SLE sera bound Clq (Fig. 1) , and four of these sera showed a fall of ClqBA in the supernatant serum after the cryoglobulin was harvested (Fig. 2) . All four isolated cryoglobulins from patients with cryoglobulinaemic purpura bound large amounts of Clq. and the ClqBA of the sera was markedly reduced by cold incubation.
Complement components C3 and C4 were quantitated by rocket immunoelectrophoresis in isolated cryoglobulins from 30 RA sera and 12 SLE sera with protein concentrations of greater than 10 Ztg/ml. Only small amounts of C3 and C4 were detected by this method (Table 1 ). C3 and C4 each accounted for a maximum of 1-5% of the serum cryoprecipitable protein. All three isolated cryoglobulins tested from patients with cryoglobulinaemic purpura contained both C3 and C4. Although cryoglobulins from these patients contained C3 and C4 in greater amounts than cryoglobulins from RA and SLE patients, the highest proportion of cryoglobulin accounted for by these complement components was 0-7%.
Discussion
This paper compares the characteristics of cryoglobulins isolated from the sera of patients with RA and SLE in order to ascertain whether there are differences which may explain the different clinical features seen in these two conditions.
In this study, which included only patients with cryoglobulinaemia, the amounts and ratios of the immunoglobulin classes precipitated from sera of patients with RA and SLE was approximately the same. IgG was the predominant immunoglobulin class which is in agreement with previous findings in SLE cryoglobulins, '5 The comparison performed in this paper showed the presence of DNA binding activity in cryoglobulins from patients with RA and SLE and from one patient with cryoglobulinaemic purpura. The incidence and level of DNA binding was higher in SLE cryoglobulins than in the other two conditions. Both DNA and DNA binding activity have previously been shown to be concentrated in cryoglobulins from patients with SLE.14 16 We also found a high incidence of DNA binding in RA 
